Stocks › QGEN
QIAGEN N.V.
QGEN·NYSE·USD
$45.65
-0.14 (-0.31%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
QGEN
QIAGEN N.V. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
QGENS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of QGEN by members of U.S. Congress · 16 on record
Whale Activity
Position changes in QGEN reported for 2026-06-30 by 10 tracked institutional filers
- Increased7
- New0
- Held0
- Decreased1
- Closed0
- No prior filing2
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 6.2M | $240.2M | increased |
| BlackRock, Inc. | 5.9M | $230.9M | increased |
| MILLENNIUM MANAGEMENT LLC | 3.8M | $150.4M | increased |
| Point72 Asset Management, L.P. | 1.6M | $62.1M | increased |
| CITADEL ADVISORS LLC | 832.4K | $32.5M | increased |
| DNCA FINANCE | 759.6K | $29.4M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 201.3K | $7.9M | increased |
| D. E. Shaw & Co., Inc. | 74.3K | $2.9M | increased |
| One68 Global Capital, LLC | 25.2K | $975K | — |
| TWO SIGMA INVESTMENTS, LP | 14.3K | $560K | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by QGEN insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
0 transactions on record · newest first
No insider transactions on record.
Fund Holders
Mutual funds and ETFs holding QGEN · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Disciplined Value Mid Cap Fund John Hancock Funds III | 2.5M | $101.7M | 0.46% | Mar 31, 2026 |
| International Equity Fund Principal Funds, Inc | 1.8M | $73.1M | 1.13% | Jul 31, 2026 |
| Victory Sycamore Small Company Opportunity Fund Victory Portfolios | 1.0M | $39.3M | 0.84% | Jun 30, 2026 |
| iShares Russell 1000 Value ETF iShares Trust | 460.6K | $18.0M | 0.02% | Jun 30, 2026 |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 411.2K | $17.0M | 0.30% | Jul 31, 2026 |
| Nuveen International Equity Index Fund TIAA-CREF Funds | 326.7K | $13.4M | 0.04% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF Dimensional ETF Trust | 321.1K | $13.3M | 0.09% | Jul 31, 2026 |
| Nuveen Quant Small/Mid Cap Equity Fund TIAA-CREF Funds | 252.3K | $10.4M | 0.39% | Jul 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 249.8K | $9.8M | 0.01% | Jun 30, 2026 |
| Nuveen Equity Index Fund TIAA-CREF Funds | 200.2K | $8.3M | 0.01% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list QGEN's shares (CUSIP N72482156), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Massachusetts Financial Services CompanySCHEDULE 13G/A · passive (13G) · 12.4M shares6.0%
Jun 5, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming qiagen as client
No lobbying filings found naming QIAGEN N.V. as the client.
- HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q3 · HCR, BUD—
Filing ↗ - HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q2 · HCR, BUD—
Filing ↗ - HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q1 · HCR, BUD—
Filing ↗ - HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2020 Q1 · BUD, HCR—
Filing ↗ - HEALTH AND MEDICINE COUNSEL, LLCQIAGEN, INC. C/O D.FRASER ASSOCIATES, LLC · 2019 Q4 · HCR—
Filing ↗
Government Contracts
Federal awards to qiagen · USAspending
$5.6MAwarded · 49 contracts on record
- Department of Veterans AffairsLIASON QUANTIFERON-TB GOLD PLUSE US & CONTROL QUANTIFERON-TB GOLD PLUS.$140K
Apr 16, 2024 · ↗ - Department of Veterans AffairsQUANTIFERON TB GOLD PLUS REAGENTS AND CONTROLS$72K
Oct 1, 2026 · ↗ - Department of Veterans AffairsEO 14398 MOD TO INCORPORATE FAR 52.222-90 JAK2 MUTATION TESTING REAGENT KITS$162K
Jun 27, 2026 · ↗ - Department of AgricultureQIACUITY EIGHT INSTRUMENT, 219 FULL-SERVICE AGREEMENT.$22K
Aug 19, 2025 · ↗ - Department of CommerceEZ2 AUTODNA EXTRACTION SYSTEM OU623-FY27-017-NEW$86K
Sep 30, 2026 · ↗ - Department of Health and Human ServicesQIAGEN INC:1110297 [26-000013]$8K
Jan 1, 2026 · ↗ - Department of Health and Human ServicesIPA ANALYSIS MATCH LCL$67K
Sep 23, 2026 · ↗ - Department of Health and Human ServicesQIAGEN INC:1110297 [26-010010]$18K
Sep 22, 2026 · ↗
U.S. Patents
Recent USPTO applications naming QIAGEN N.V.
No USPTO patent applications found for QIAGEN N.V..
Annual Financials
From QGEN's 10-K filings · XBRL
No annual XBRL figures on record for QGEN. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 19-for-20Reverse splitJan 8, 2026
- 30-for-31Reverse splitJan 30, 2024
- 25-for-26Reverse splitJan 25, 2017
- 4-for-1Stock splitJul 14, 2000
- 2-for-1Stock splitJul 16, 1999
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About QIAGEN N.V.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersPL VENLO
IncorporatedP7
SEC CIK0001015820 ↗
Former namesQIAGEN NV